Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840161 · ClinicalTrials.gov registry record
Use of CoG by Patients With Diabetes Mellitus
A clinical trial, sponsored by Sciema UG.
- Completed
- Registry status
- 40
- Enrollment target
NCT03840161 is a clinical trial that has completed, run by Sciema UG. The registered enrollment target is 40 participants.
The verdict
NCT03840161 has completed, sponsored by Sciema UG.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The CNOGA Combo Glucometer (CoG) employs an invasive glucose meter using blood glucose teststrips and requiering a capillary blood sample obtained from a fingerstick and in addition, a non-invasive optical component for prediction of tissue glucose at the fingertip. In this study, participants will use both devices during meal tests and also at home during routine care. The results from the device will be compared to a standard reference method and will be used to determine the accuracy of the two device components.
Interventions
- DEVICE non-invasive tissue glucose prediction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2019-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03840161
The ClinicalTrials.gov registry entry for NCT03840161 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sciema UG, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which non-invasive tissue glucose prediction is the first listed.
NCT03840161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03840161 about?
NCT03840161 is a clinical study titled "Use of CoG by Patients With Diabetes Mellitus". The CNOGA Combo Glucometer (CoG) employs an invasive glucose meter using blood glucose teststrips and requiering a capillary blood sample obtained from a fingerstick and in addition, a non-invasive optical component for prediction of tissue glucose at the fingertip. In this study, participants will ...
What is the current status of trial NCT03840161?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-07-16. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT03840161?
The interventions under investigation include: non-invasive tissue glucose prediction (DEVICE).
Who is sponsoring clinical trial NCT03840161?
This trial is sponsored by Sciema UG, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.